Prompt benefit of early immunosuppressive therapy in acute lymphocytic myocarditis with persistent heart failure. (Q53119578)

11 May 2018

title

Prompt benefit of early immunosuppressive therapy in acute lymphocytic myocarditis with persistent heart failure. (English)

1 reference

11 May 2018

0 references

0 references

1 reference

Tatyana Weitsman

1

1 reference

11 May 2018

Giora Weisz

series ordinal

2

1 reference

11 May 2018

Andre Keren

series ordinal

3

1 reference

11 May 2018

Tal Hasin

series ordinal

4

1 reference

11 May 2018

publication date

18 April 2016

1 reference

11 May 2018

Clinical Research in Cardiology

published in

1 reference

11 May 2018

volume

105

1 reference

11 May 2018

issue

9

1 reference

11 May 2018

page(s)

794-796

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1007/s00392-016-0985-x

exact match

0 references

cites work

A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-0985-X

Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-0985-X

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-0985-X

Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-0985-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-0985-X

Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-0985-X

HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27091051

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Viral damage or 'molecular mimicry'-placing the blame in myocarditis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27091051

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27091051

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00392-016-0985-X

1 reference

11 May 2018

PubMed ID

27091051

1 reference

11 May 2018